Community 1784797642858 New Gene Therapy Company Tern Therapeutics Launched By Former Regenxbio Executives To Advance Treatments For Rare Diseases Including Ocular Manifestations Of Cln2 Batten Disease

Read this inherited retinal disease research and education article from the A Race Against Blindness IRD Education Hub, then explore related conditions, genes, trials, and support resources.